Call to fund Meningococcal B vaccine

ONE of Australia’s leading immunisation advocates has called for funding of the meningococcal B vaccine (MenBV) for at least five years.

Meningococcal B vaccine

Professor Robert Booy, paediatric infectious diseases specialist at the University of Sydney, says MenBV hasn’t made it on to the National Immunisation Program (NIP) because “it doesn’t look cost effective”.

However, he says, the true cost of the disease is “huge” when long-term physical, neuropsychological and